One trade group has already filed a lawsuit to try to reverse the decision. Meanwhile, a similar fight over Novo Nordisk’s wildly popular drugs Ozempic and Wegovy looms. Semaglutide, the active ...
In the six years since Ozempic's release, the drug has grown from a relative newcomer on the market into a dominating force in the weight loss industry - one inspiring a handful of similar medications ...